Skip to main content

EDITORIAL article

Front. Endocrinol.
Sec. Thyroid Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1554563
This article is part of the Research Topic Thyroid Endocrine Disruptors View all 10 articles

Endocrine Disruptors and Their Multiple Effects on Thyroid Function: Crucial Data Acquired Through a Collection of Research Papers

Provisionally accepted
  • 1 Evgenidion Hospital, National University Of Athens, Athens, Greece
  • 2 Scientific Clinical Institute Maugeri (ICS Maugeri), Pavia, Lombardy, Italy

The final, formatted version of the article will be published soon.

    Assembling a collection or series of articles is a well-known method of compiling a thesis based on published work. Another means is to gather several research papers highlighting a specific scientific area and include an introductory section and a summary of corresponding chapters.Eight papers over the last 3 years in Frontiers of Endocrinology have been collected and summarized in this Editorial to heighten collective awareness of the impact of toxic environmental elements, mainly endocrine chemical disruptors, on thyroid function and disease pathogenesis. (3). A total of 17 articles were analyzed of which 13 studies were observational and four interventional. Some studies showed a negative association of triclosan with T3 and T4 and a positive association with TSH, others showed the opposite, and the rest found no association. The authors thus concluded that due to the limited data, more interventional and well-controlled studies are needed to determine whether triclosan affects thyroid function.Coperchini F. et al. studied the effects of per-and polyfluoroalkyl substances (PFAS), a group of synthetic compounds widely used in industry plants due to their low grade of degradation and flame resistance, on thyroid function (4). These characteristics are potentially dangerous for both human health and the environment. PFAS are persistent pollutants accumulating in water and soil that may be found in foods given that the chemicals are often used in disposable food packaging. Due to their persistence and potential harm to human health, some old-generation PFAS have been replaced by newly synthesized, allegedly safer PFAS. Even though exposure to PFAS in the environment remains a matter of concern worldwide, data on the thyroid-disrupting effect of these chemicals and on their impact on human health at different ages remain controversial. Benvenga S. et al. examined the effects of myo-inositol (MI), seleno-L-methionine (Se), combined cMI + Se, and resveratrol on C cells of mice exposed to cadmium chloride (Cd Cl2) (5). Previous studies showed that CdCl2 may induce hyperplasia and hypertrophy of C cells. C57 BL/6J adult male mice were studied for 14 days. Se at either 0.2 or 0.4 mg/kg/day failed to significantly increase follicular mean diameter while mildly decreasing calcitonin (Ct) positive cell number. In contrast, MI alone significantly increased follicular mean diameter number and substantially decreased CT-positive cell number, area, and cytoplasmic density. MI + Se 0.2 mg/kg/ day or MI + Se 0.4 mg/kg/day administration appreciably improved all five indices. Furthermore, it has been hypothesized that the action of Se-dependent antioxidant enzymes may protect against Cd toxicity, thus reducing the oxidative stress and counteracting the apoptosis induced by endoplasmic reticulum stress Although iodine 131 ( 131 I) is the main therapeutic tool for distant metastases of differentiated thyroid cancer, 131 I overtreatment exerts many disrupting effects on several organ systems (6). However, Sa R. et al. found that two parameters can be used to predict the need for further 131 I treatments, namely, Delta Tg % (pre-therapeutic Tg-posttherapeutic Tg/pre-therapeutic Tg × 100%) and maximum target/ background ratio (T/Bmax) in each Rx (post 313 I)-WBS. Using these parameters 131I overtreatment can be avoided.Wang J. et al. investigated whether helicobacter pylori (H-pylori) infection has a thyroiddisrupting effect (7). They found that H. pylori seropositive subjects had higher serum TSH than those with H. pylori seronegative. In stratified analyses, the adjusted association of serum TSH with H. pylori seropositivity was statistically significant in male, normal BMI, overweight, obese, and over 60-year-old subjects.In their study, Chen Y. et al. investigated thyroid function a year after percutaneous coronary intervention (PCI) (8). PCI treatments result in the absorption of large volumes of iodinated contrast media (ICM) by administering ICM doses ranging from 80 to 530 mL.The main results were the following: (i) the serum level of FT4 was significantly increased;(ii) the volume of ICM correlated with composite endpoints and hyperthyroidism with a nonlinear dose-response relationship; and (iii) the risk of hyperthyroidism increased in the high-volume ICM patient group. This indicates the need to check thyroid function in PCI-treated patients carefully.In practice: Several compounds, including synthetic substances, metals, contrast media, and radioiodine, are strongly suspected of being endocrine disruptors that affect thyroid and parathyroid function and thereby induce disease. However, no large studies exist to date demonstrating that the studied chemicals and metals exert thyroid disruption. The results of the above-presented recent and important papers are anticipated to increase awareness of the multiple risks of EDC exposure to thyroid health among researchers and the public.

    Keywords: Endocrine Disruptors, Thyroid function, Per-and polyfluoroalkyl substances (PFAS), Selenomethionine, Helicobacter pylori

    Received: 02 Jan 2025; Accepted: 14 Jan 2025.

    Copyright: © 2025 Duntas and Chiovato. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Leonidas H. Duntas, Evgenidion Hospital, National University Of Athens, Athens, 115 28, Greece

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.